StonvexLoading…
StonvexStonvexStonvexCore line items from AMSC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 | Annual 2022 2022-03-31 |
|---|---|---|---|---|
Revenue | $222.82M | $145.64M | $105.98M | $108.44M |
Operating Income | $-1.08M | $-11.37M | $-33.01M | $-21.09M |
Net Income | $6.03M | $-11.11M | $-35.04M | $-19.19M |
EPS (Diluted) | $0.16 | $-0.37 | $-1.26 | $-0.71 |
Total Assets | $310.52M | $232.77M | $175.56M | $173.89M |
Total Liabilities | $113.41M | $88.20M | $93.76M | $64.50M |
Cash & Equivalents | $79.49M | $90.52M | $23.36M | $40.58M |
Free Cash Flow OCF − CapEx | $25.87M | $1.20M | $-23.72M | $-19.91M |
Shares Outstanding | 39.48M | 36.95M | 29.54M | 28.52M |